Fundraising Fox

Oncternal Therapeutics

Del Mar, US · Founded 2013 · Delaware corporation · 1 known investors

Clinical-stage oncology company developing cancer treatments

Biotech

Founders & leadership

DM
Dana McGowanTreasurer and Secretary
KL
Karen LundgrenVice President and Chief Scientific Officer
LG
Lauren G. OtsukiChief Business Officer
JF
James FreddoChief Medical Officer
DF
David F. HaleDirector
SG
Scott GlennDirector
CG
Cam GarnerDirector
JB
James B. Breitmeyer, M.D., Ph.D.President and Chief Executive Officer
DJ
David JohnsonDirector

Investors · 1

Vedanta CapitalNew York

Reported raises · per SEC filings

Form D private placements
▶$17MraisedNov 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard VincentExecutive Officer
  • Cam GallagherDirector
  • Scott L. GlennDirector
  • James B. Breitmeyer, M.D., Ph.D.Executive Officer, Director
  • Cooper CollinsDirector
  • David F. HaleDirector
  • Charles Theuer, M.D.Director
  • Lauren G. OtsukiExecutive Officer
  • William R. LaRueDirector
Offering amount
$24M
Amount sold
$17M
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.9MraisedSep 2017 · 121 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David JohnsonDirector
  • James B. Breitmeyer, M.D., Ph.D.Executive Officer, Director
  • Scott L. GlennDirector
  • Richard VincentExecutive Officer
  • Lauren G. OtsukiExecutive Officer
  • Cooper CollinsDirector
  • Brian LannuttiExecutive Officer
  • Cam GarnerDirector
  • Cam GallagherDirector
  • David F. HaleDirector
  • Langdon MillerExecutive Officer
Offering amount
$11.3M
Amount sold
$6.9M
First sale
Sep 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$17.9MraisedMar 2017 · 111 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott L. GlennDirector
  • Brian LannuttiExecutive Officer
  • Cam GarnerDirector
  • Cam GallagherDirector
  • David F. HaleDirector
  • Langdon MillerExecutive Officer
  • Lauren G. OtsukiExecutive Officer
  • David JohnsonDirector
  • James B. Breitmeyer, M.D., Ph.D.Executive Officer, Director
Offering amount
$23.5M
Amount sold
$17.9M
First sale
Jul 2015
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$150KraisedJul 2016 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Lauren G. OtsukiExecutive Officer
  • David F. HaleDirector
  • James B. Breitmeyer, M.D., Ph.D.Director, Executive Officer
  • David JohnsonDirector
  • James FreddoExecutive Officer
  • Brian LannuttiExecutive Officer
  • Dana McGowanExecutive Officer
  • Scott GlennDirector
  • Cam GarnerDirector
Offering amount
$3.3M
Amount sold
$150K
First sale
Jun 2016
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13.1MraisedJun 2016 · 26 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dana McGowanExecutive Officer
  • Karen LundgrenExecutive Officer
  • Lauren G. OtsukiExecutive Officer
  • James FreddoExecutive Officer
  • David F. HaleDirector
  • Scott GlennDirector
  • Cam GarnerDirector
  • James B. Breitmeyer, M.D., Ph.D.Director, Executive Officer
  • David JohnsonDirector
Offering amount
$13.1M
Amount sold
$13.1M
First sale
May 2016
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.